Disc Medicine, Inc. (NASDAQ:IRON) is one of the 13 Small Cap Stocks Analysts Are Bullish On. In a report released on June 16, ...

Non-profit organization I Want To Share Foundation (IWTS) once again hosted the “CAn Beat It” ceremony to officially honor the resilience of 115 pediatric cancer survivors who successfully completed ...

PDUFA action date set for October 25, 2025 – – sNDA being reviewed under FDA’s RTOR program – – Revumenib has the potential to become the first and only menin inhibitor approved in both R/R mNPM1 AML ...

With the summer humidity plopped right over Central New York, catching a flick in a nice air-conditioned theater may not sound too bad. This week, Bridge Street’s Brian ...

National Review's latest articles covering news, politics, current events, elections, and culture with detailed analysis and commentary.

Those threats are just one example of the rising incidence of patient incivility in health care. Sexual harassment, misogyny, ...

Investing.com -- Syndax Pharmaceuticals Inc (NASDAQ: SNDX) stock gained 2.5% after the FDA granted Priority Review for its supplemental New Drug Application (sNDA) for Revuforj, potentially expanding ...

The study reviews CAR-T cell advancements in lymphoma treatment, addressing T cell exhaustion and tumor immune evasion with ...

In a cohort of TRANSCEND FL, the chimeric antigen receptor T-cell therapy liso-cel showed a 95% overall response rate in relapsed marginal zone lymphoma, offering hope for improved patient outcomes in ...

There has been no or some progress in most areas since a National Institute of Health consensus development project in 2020, according to a group of experts. But exception is important: Prevention of ...

Researchers sought to determine risk of venous thromboembolism, based on SAVED and IMPEDE VTE scores, in patients with newly diagnosed multiple myeloma.